Onorina Laura Manzo

Ph.D in pharmacology. Born in Italy, based in New York. Passionate in discovering targets involved in cardiometabolic disorders. Any question needs an answer.

[Onorina Laura Manzo @ManzoNory]

When Protective Lipids Decline, Health Risks Increase https://t.co/aVxWhgHJWq

[Onorina Laura Manzo @ManzoNory]

It’s incredibly fascinating how few excellent minds can impact a whole population’s life. So proud of you and congratulations for your hard work and the amazing results. 👏🏻👏🏻👏🏻

[Emanuela Ferraro, MD @EmaFer_90]

BrMs are the Achilles' heel of HER2+ breast cancer. We MUST do more and sharpen our focus on their patterns of presentation when designing clinical trials for this population. Our latest work shows that BrMs are not all the same. Check this out ⬇️🚀#bcsm @MSK_DeptOfMed @Dr_N_Moss

[Onorina Laura Manzo @ManzoNory]

Solving the Riddle of the Sphingolipids in Coronary Artery Disease https://t.co/vWhf8sPsgp

Adding new insights to this fascinating unknown sphingolipids world. 🤔

[Annarita Di Lorenzo @ar_dilorenzo]

So excited for the publication of our manuscript in @CircRes online on Women’s Day! Congrats to @ManzoNory @LindaSasset @Luisa @AliceMarino_ @jasminenour7 @SmimmoMartina
I am so proud of you! Many thanks to all the coauthors, especially our collaborators @ElementoLab @LabFreed

[Emanuela Ferraro, MD @EmaFer_90]

Such a special Women's Day for @ManzoNory & DiLorenzo Lab @WeillCornell ! Kudos for this amazing work! 🚀💫🇮🇹 #WomenInScience

[Onorina Laura Manzo @ManzoNory]

@ar_dilorenzo @LindaSasset @jasminenour7 @SmimmoMartina @alice

[Onorina Laura Manzo @ManzoNory]

Excited to share our innovative work about the beneficial role of endothelial Sphingolipid metabolism in coronary atherosclerosis. Thanks to all the amazing collaborators that contributed to my personal and scientific growth! https://t.co/Sg14mT5WJs